少之又少：HIV 可能逃避抗体亲和力的方式 - Suppr

Suppr

超能文献

Few and far between: how HIV may be evading antibody avidity.

作者信息

Klein Joshua S, Bjorkman Pamela J

机构信息

Division of Biology, California Institute of Technology, Pasadena, California, United States of America.

出版信息

PLoS Pathog. 2010 May 27;6(5):e1000908. doi: 10.1371/journal.ppat.1000908.

DOI:10.1371/journal.ppat.1000908

PMID:20523901

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2877745/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae97/2877745/e2aa99a9e23c/ppat.1000908.g001.jpg

相似文献

Few and far between: how HIV may be evading antibody avidity.少之又少：HIV 可能逃避抗体亲和力的方式

PLoS Pathog. 2010 May 27;6(5):e1000908. doi: 10.1371/journal.ppat.1000908.

Challenges of antibody-mediated protection against HIV-1.抗体介导的抗HIV-1保护面临的挑战。

Expert Rev Vaccines. 2010 Jul;9(7):683-7. doi: 10.1586/erv.10.70.

HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention?HIV-1 自身反应性抗体：它们对 HIV-1 预防是好是坏？

Nat Struct Mol Biol. 2010 May;17(5):543-5. doi: 10.1038/nsmb0510-543.

Origins of a Vaccine-Induced, Human Anti-HIV-1 Antibody.一种疫苗诱导的人类抗HIV-1抗体的起源

EBioMedicine. 2015 Jul 16;2(7):632-3. doi: 10.1016/j.ebiom.2015.07.019. eCollection 2015 Jul.

Population-based analysis of HIV-1 antibodies reveals structural constraints that may inform vaccine design.

AIDS. 2015 Sep 24;29(15):N13. doi: 10.1097/QAD.0000000000000832.

Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.一种靶向HIV-1 gp120 CD4结合位点的新型中和抗体的分离与鉴定。

Antiviral Res. 2016 Aug;132:252-61. doi: 10.1016/j.antiviral.2016.06.013. Epub 2016 Jul 5.

HIV/AIDS: allied responses.艾滋病毒/艾滋病：联合应对措施

Nature. 2007 Sep 6;449(7158):29-30. doi: 10.1038/449029a.

High avidity anti-integrase antibodies discriminate recent and non-recent HIV infection: Implications for HIV incidence assay.高亲和力抗整合酶抗体可区分近期和非近期 HIV 感染：对 HIV 发病率检测的影响。

J Virol Methods. 2018 Mar;253:5-10. doi: 10.1016/j.jviromet.2017.12.003. Epub 2017 Dec 14.

Immunology. Close to the edge: neutralizing the HIV-1 envelope.免疫学。接近边缘：中和HIV-1包膜。

Science. 2005 Jun 24;308(5730):1878-9. doi: 10.1126/science.1114854.

What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?基于离液剂的HIV-1包膜糖蛋白抗体亲和力测定法测量的是什么？

J Virol. 2015 Jun;89(11):5981-95. doi: 10.1128/JVI.00320-15. Epub 2015 Mar 25.

引用本文的文献

Molecular ingredients of an immunogen for long-lasting IgG.用于产生持久IgG的免疫原的分子成分。

Front Immunol. 2025 Aug 19;16:1639371. doi: 10.3389/fimmu.2025.1639371. eCollection 2025.

Understanding antibody-target antigen interactions and the avidity effect using mathematical modelling.利用数学建模理解抗体-靶抗原相互作用及亲和力效应。

J R Soc Interface. 2025 Jul;22(228):20240710. doi: 10.1098/rsif.2024.0710. Epub 2025 Jul 9.

Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein.对经鼻内给予严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白所诱导的鼻腔免疫球蛋白A（IgA）抗体的综合分析。

Elife. 2025 May 8;12:RP88387. doi: 10.7554/eLife.88387.

Superior Potency of Synthetic Virus-like Structures in Vaccine-Induced Antibody Responses Compared to Qβ Bacteriophage Virus-like Particles.与Qβ噬菌体病毒样颗粒相比，合成病毒样结构在疫苗诱导的抗体反应中具有更高的效力。

Viruses. 2025 Apr 17;17(4):579. doi: 10.3390/v17040579.

Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.抗丙型肝炎病毒E1E2包膜糖蛋白的双特异性抗体。

Proc Natl Acad Sci U S A. 2025 Apr 15;122(15):e2420402122. doi: 10.1073/pnas.2420402122. Epub 2025 Apr 7.

The molecular reach of antibodies crucially underpins their viral neutralisation capacity.抗体的分子作用范围对其病毒中和能力起着至关重要的支撑作用。

Nat Commun. 2025 Jan 2;16(1):338. doi: 10.1038/s41467-024-54916-5.

The consequences of SARS-CoV-2 within-host persistence.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在宿主体内持续存在的后果。

Nat Rev Microbiol. 2025 May;23(5):288-302. doi: 10.1038/s41579-024-01125-y. Epub 2024 Nov 25.

Intra-channel bi-epitopic crosslinking unleashes ultrapotent antibodies targeting Na1.7 for pain alleviation.通道内双表位交联释放针对 Na1.7 的超强效抗体，用于缓解疼痛。

Cell Rep Med. 2024 Nov 19;5(11):101800. doi: 10.1016/j.xcrm.2024.101800. Epub 2024 Oct 25.

Antiretroviral Therapy with Ritonavir-Boosted Atazanavir- and Lopinavir-Containing Regimens Correlates with Diminished HIV-1 Neutralization.使用利托那韦增强的含阿扎那韦和洛匹那韦方案的抗逆转录病毒疗法与HIV-1中和作用减弱相关。

Vaccines (Basel). 2024 Oct 17;12(10):1176. doi: 10.3390/vaccines12101176.

Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.探索 HIV-1 成熟：抗病毒药物开发的新前沿。

Viruses. 2024 Sep 6;16(9):1423. doi: 10.3390/v16091423.

本文引用的文献

Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity.结构一个 clade C HIV-1 gp120 结合 CD4 和 CD4 诱导的抗体揭示抗 CD4 多反应性。

Nat Struct Mol Biol. 2010 May;17(5):608-13. doi: 10.1038/nsmb.1796. Epub 2010 Mar 31.

Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.HIV-1 gp120上CD4附着位点免疫逃逸的结构基础。

Science. 2009 Nov 20;326(5956):1123-7. doi: 10.1126/science.1175868.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.在泰国使用ALVAC和AIDSVAX疫苗预防HIV-1感染。

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

HIV vaccine trial results--an opening for further research.艾滋病病毒疫苗试验结果——进一步研究的契机

N Engl J Med. 2009 Dec 3;361(23):2279-80. doi: 10.1056/NEJMe0909972. Epub 2009 Oct 20.

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.广泛中和抗体的种系样前体对HIV-1包膜糖蛋白缺乏可检测到的结合：对免疫反应逃逸和疫苗免疫原设计的影响。

Biochem Biophys Res Commun. 2009 Dec 18;390(3):404-9. doi: 10.1016/j.bbrc.2009.09.029. Epub 2009 Sep 11.

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.一位非洲捐赠者体内广泛且强效的中和抗体揭示了一个新的HIV-1疫苗靶点。

Science. 2009 Oct 9;326(5950):285-9. doi: 10.1126/science.1178746. Epub 2009 Sep 3.

Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?自然HIV-1感染过程中产生的中和抗体：对HIV-1疫苗来说是好消息吗？

Nat Med. 2009 Aug;15(8):866-70. doi: 10.1038/nm.1949.

HIV-1 and influenza antibodies: seeing antigens in new ways.HIV-1与流感抗体：以新方式识别抗原

Nat Immunol. 2009 Jun;10(6):573-8. doi: 10.1038/ni.1746.

Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.广泛中和性人类抗HIV抗体2G12即使在血清中和效价较低时，也能有效保护机体免受黏膜猴-人免疫缺陷病毒攻击。

PLoS Pathog. 2009 May;5(5):e1000433. doi: 10.1371/journal.ppat.1000433. Epub 2009 May 15.

Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.抗HIV抗体b12和4E10的大小和亲和力对中和机制贡献的研究。

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7385-90. doi: 10.1073/pnas.0811427106. Epub 2009 Apr 16.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验